Science 37 and Signant Health Partner to Expand Access to CNS Research
Science 37 and Signant Health (Signant) have announced a partnership to strengthen capabilities for decentralized or virtual central nervous system (CNS) clinical research.
This collaboration brings together Science 37’s decentralized trial capability and Signant’s data collection technologies, offering sponsors and sites digitally enabled solutions for conducting CNS studies. The combined capabilities span Science 37’s network of patients, telemedicine investigators, central raters, mobile nurses, and technology platform to orchestrate decentralized clinical trials, as well as Signant’s electronic clinical outcomes assessment (eCOA) software, rater training, randomized and trial supply management (RTSM) technology, and are supported by Signant’s long-standing scientific expertise in the CNS space.
The result is a CNS-specific technology and services platform that enables sponsors and sites to offer patients more convenience and choice across various clinical trial models, including virtual and hybrid.
“At Science 37, we strive to bring clinical trials to patients where they live—eliminating the burdens of a traditional site model and increasing patient’s access to clinical research,” said David Coman, CEO of Science 37. “By partnering with Signant Health, we enhance that offering with proven CNS expertise to operationalize and make virtual trials the new reality.”
For more information, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
